Evaluation of thermosensitive chitosan hydrogel containing gefitinib loaded cellulose acetate butyrate nanoparticles in a subcutaneous breast cancer model
- 19 July 2022
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 624, 122036
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Optimization and charaterization of repaglinide biodegradable polymeric nanoparticle loaded transdermal patchs: In vitro and in vivo studiesColloids and Surfaces B: Biointerfaces, 2013
- Grape Polyphenols Inhibit Akt/Mammalian Target of Rapamycin Signaling and Potentiate the Effects of Gefitinib in Breast CancerNutrition and Cancer, 2012
- Optimization, in vitro–in vivo Evaluation, and Short-term Tolerability of Novel Levofloxacin-loaded PLGA Nanoparticle FormulationJournal of Pharmaceutical Sciences, 2012
- Local drug delivery strategies for cancer treatment: Gels, nanoparticles, polymeric films, rods, and wafersJournal of Controlled Release, 2012
- In vivo efficacy of paclitaxel-loaded injectable in situ-forming gel against subcutaneous tumor growthInternational Journal of Pharmaceutics, 2010
- Polymeric matrix for drug delivery: Honokiol‐loaded PCL‐PEG‐PCL nanoparticles in PEG‐PCL‐PEG thermosensitive hydrogelJournal of Biomedical Materials Research Part A, 2009
- Gefitinib–cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studiesDrug Development and Industrial Pharmacy, 2009
- The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinibJournal of Cellular Physiology, 2006
- Cellulose acetate butyrate microcapsules containing dextran ion-exchange resins as self-propelled drug release systemBiomaterials, 2005
- Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cellsEndocrine-Related Cancer, 2004